Zepbound® (tirzepatide) is an FDA-approved medication for weight loss and long-term weight management. As a GLP-1 and GIP receptor agonist, it helps regulate blood sugar, reduce appetite, and boost metabolic function—making it a powerful option for effective weight reduction.
Why Choose Zepbound?
To learn more about Zepbound’s FDA approval for weight loss and hear real patient experiences, visit Coastal Wellness MD.
Select your preferred date & time
Stay updated on your upcoming appointment
Urgent & General Health needs diagnosed & treated comfortably
Yes. Zepbound is FDA-approved for weight loss. Mounjaro is approved for diabetes but used off-label. Both contain tirzepatide and offer up to 22% weight loss in trials.
Tirzepatide activates both GLP-1 and GIP hormones—helping suppress appetite, increase satiety, and improve insulin function even more powerfully than GLP-1s alone.
Patients often lose 20–22% of their body weight with lifestyle support.
Yes. Side effects are similar to GLP-1s but may include more GI symptoms in early weeks.
Same as GLP-1: patients with thyroid cancer history, MEN2, severe GI disorders, or known allergies to tirzepatide.
Yes. We evaluate A1C, glucose, thyroid, kidney, and liver function before treatment.
These are weekly auto-injections. We walk you through step-by-step use.
Mostly GI-related: nausea, bloating, constipation. Rare but possible: gallbladder issues, pancreatitis, allergic reactions.
Your wellness experience starts here. Submit your inquiry and we’ll take care of the rest.
